Association of sociodemographic characteristics with utilization of sentinel lymph node biopsy for American Joint Committee on Cancer 8th edition T1b cutaneous melanoma-Reference-Cited by-同舟云学术

Association of sociodemographic characteristics with utilization of sentinel lymph node biopsy for American Joint Committee on Cancer 8th edition T1b cutaneous melanoma

Published:2023-05-30 Issue:9 Volume:315 Page:2697-2701
ISSN:1432-069X
Container-title:Archives of Dermatological Research
language:en
Short-container-title:Arch Dermatol Res

Author:

Zheng David X.,Ahmed Fasih A.,Levoska Melissa A.,Tripathi Raghav,Mulligan Kathleen M.,Cwalina Thomas B.,Bordeaux Jeremy S.,Ruiz Emily S.,Rothermel Luke D.,Hoehn Richard S.,Scott Jeffrey F.

Publisher

Springer Science and Business Media LLC

Subject

Dermatology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00403-023-02641-2.pdf

Reference12 articles.

1. Swetter SM, Thompson JA, Albertini MR et al (2021) NCCN guidelines(R) insights: melanoma: cutaneous, version 2.2021. J Natl Compr Canc Netw. 19(4):364–76

2. Bilimoria KY, Balch CM, Wayne JD et al (2009) Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States. J Clin Oncol 27(11):1857–1863

3. Narang J, Hue JJ, Bingmer K et al (2021) Sentinel lymph node biopsy guideline concordance in melanoma: analysis of the national cancer database. J Surg Oncol 124(4):669–678

4. Mallin K, Browner A, Palis B et al (2019) Incident cases captured in the national cancer database compared with those in U.S. population based central cancer registries in 2012–2014. Ann Surg Oncol. 26(6):1604–12

5. Swords DS, Mulvihill SJ, Brooke BS, Skarda DE, Firpo MA, Scaife CL (2019) Disparities in utilization of treatment for clinical stage I-II pancreatic adenocarcinoma by area socioeconomic status and race/ethnicity. Surgery 165(4):751–759